Skip to content

An Investigation Into the Effects of a Wild Blueberry Powder and a Wild Blueberry Extract on Cognition in Older Adults

A Randomized, Double-blind, Placebo-controlled Study Investigating the Effects of a Wild Blueberry Powder and a Wild Blueberry Extract on Cognition in Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02446314
Enrollment
122
Registered
2015-05-18
Start date
2015-05-31
Completion date
2017-07-31
Last updated
2019-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Decline

Brief summary

The purpose of this study is to determine whether a 6 month dietary intervention with wild blueberry powder and extract stabilised with L-cysteine and L-glutathione have an effect on cognitive performance in participants aged between 65 - 80.

Detailed description

Interventions: A placebo and two different wild blueberry products will be used in this study (see Table 1). A wild blueberry powder at two different doses and a single wild blueberry extract. The wild blueberry powder will be used at a 450 mg-dose, to which 45 mg of L-Cysteine and 5 mg of L-Glutathione will be added (wild blueberry powder-450), as well as at a 900 mg-dose, to which 90 mg of L-Cysteine and 10 mg of L-Glutathione will also be added (wild blueberry powder-900). The wild blueberry extract will consist of 100 mg of wild blueberry extract supplemented with 10 mg of L-Cysteine and 1 mg of L-Glutathione. Participants will be asked to consume two capsules daily with their normal breakfast. The capsules will be packed in blister packs with 4 capsules per blister. Each box contains 4 blisters (or a total of 16 capsules) in order to provide for 1 week of study medication, with 2 capsules remaining. Participants will be instructed to return the left-over investigational product weekly (i.e two capsules) using stamped addressed envelopes supplied by the experimenters. Weekly assessment of left-over investigational product will allow for continued compliance verification. Procedure: The study comprises of a telephone screen and then six visits, including a familiarization visit (week T-1), three test visits (week 0, 12 and 24), and two control visits (week 6 and 18). Participants may stop the study treatment without stating any reason at any time during the study. In addition, a participant will be withdrawn from the study if: a subject requests discontinuation, he/she exhibits a serious adverse event to any component of the test product, the participant significantly violates the inclusion or exclusion criteria, an intercurrent illness emerges and/or the investigator's opinion is that withdrawal is appropriate and in the best interest of the participant. If a participant withdraws from the study, he/she will be encouraged to make a final visit as soon as possible, irrespective of the reason for withdrawal, to complete a final battery of cognitive tasks. 1. Screening: once a participant has indicated that they wish to join the trial they will be contacted by telephone for a brief screening session. The research associate (RA) will give a brief overview of the study and will ascertain that each interested volunteer is willing to participate for the entire duration of the study and to check that they fulfill our inclusion/exclusion criteria. Once confirmation of suitability for the study is confirmed, the RA will schedule their familiarization visit. 2. Familiarization Visit: Volunteers will be asked to attend the Nutritional Psychology Unit at the University of Reading where they will receive a detailed explanation on the study by the participating research associate and will be asked to sign the informed consent form before any study procedure starts. A log will be kept identifying all participants having signed the informed consent form (ICF) and the participant will be allocated a participant number. Once consent has been given, the inclusion/exclusion criteria will be checked once again and vital signs (blood pressure and heart rate) and anthropometric measurements (height, weight, BMI) will be taken. The participants will then be asked to complete a number of questionnaires and cognitive tasks comprising: (i) Yale Physical Activity Questionnaire; (ii) Frequency of Forgetting Questionnaire to give a baseline assessment of their memory performance; and (iii) Computerized Global Cognitive Health Assessments (NART, CERAD, MMSE, letter and category fluency; unless as a member of the Older Adult Panel these data have been collected from them in the preceding 3 months). Finally, participants will be given training on the cognitive test battery (tasks outlined below) that will be used during the study to reduce the chances of 'practice' adversely effecting performance on subsequent test days. Before leaving the laboratory, participants will be asked to keep a 72 hour food diary (consisting of 2 week days & 1 weekend day) so that background flavonoid intakes can be measured prior to the start of the intervention. 3. Test Visits (Weeks 0, 12 and 24): All of these sessions will be held in the morning (typically 8am-10am arrival time to suit participants individual needs). Participants will attend the laboratory in a fasted state and on arrival at the laboratory we will check participants still fulfill our inclusion/exclusion criteria, their general well-being, notification of any adverse events, any issues with compliance, and to check whether there have been changes to any concomitant medication. Blood pressure and heart rate will also be measured, and the food diary will be collected (week 0 and 24 only). They will then receive a standard low-flavonoid breakfast and will complete the battery of cognitive tasks (see below). Subjects will then be given their intervention (sufficient quantity until their next test session, in blister packs, weeks 0 and 12 only), and will then be requested to consume 2 capsules each day. At week 24 only, the Yale Physical Activity and Frequency of Forgetting questionnaires will also be administered, and weight will be measured. 4. Control Visits (weeks 6 & 18): These sessions can take place at any time of day to suit the participant. Participants will attend the laboratory at the University of Reading to collect the next 6 week supply of their intervention. During these visits we will check that participants still fulfill our inclusion/exclusion criteria, informally check their well-being, inquire whether there have been any adverse events, and confirm that there have not been any changes to their concomitant medication. At week 18 only participants will be given another copy of the 72 hour food diary (consisting of 2 week days & 1 weekend day and asked to complete this before they return for their test visit in week 24.

Interventions

DIETARY_SUPPLEMENTPlacebo

Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen

DIETARY_SUPPLEMENTWild Blueberry Powder - 450mg

Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen

DIETARY_SUPPLEMENTWild Blueberry Powder - 900 mg

Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen

DIETARY_SUPPLEMENTWild Blueberry extract 100mg

Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen

Sponsors

Naurex, Inc, an affiliate of Allergan plc
CollaboratorINDUSTRY
University of Reading
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Overall healthy volunteers as proven by medical history and/or physical examination and of all ethnicity and socioeconomic status * Free-living * Subjects with subjective memory complaints * MMSE: 24-30 * Subjects are willing to maintain their normal eating habits and exercise habits to avoid changes in body weight over the duration of the study * Being willing to complete the food diaries and questionnaires * Able to give signed written informed consent * Signed informed consent form

Exclusion criteria

* Use of complementary and alternative medicine * History of metabolic disorder, diabetes, substance abuse * Subjects diagnosed with psychiatric or neurological conditions * Subjects using medications that might affect the outcome measures (such as antidepressant and sleeping medication), or planned changes

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Words Correctly Recognised.12, and 24 weeksParticipants indicate whether words presented on a monitor are from a list of 15 words previously presented auditorily (via headphones), or if they are novel foils.
Total Number of Correct Sequences Recalled12, and 24 weeksParticipants view an array of 9 white squares on a monitor which light up red in sequences of between 2 and 9. They are then required to press the correct squares in the sequence they were presented.
Combined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.12, and 24 weeksCombined Z score of proportion of words recalled, proportion of words recognised, and proportion of pictures recognised. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome

Secondary

MeasureTime frameDescription
Diastolic Blood Pressure12, and 24 weeksLMM analysis of intervention group x 12 and 24 wk test session. Baseline blood pressure entered as a covariate.
Heart Rate12, and 24 weeks.LMM analysis of intervention group x 12 and 24 wk test session. Baseline heart rate entered as a covariate.
Combined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.12, and 24 weeksCombined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome.
Negative Affect Score12, and 24 weeks.As measured by the negative mood scale derived from the Positive and Negative Affect Schedule. This measure consists of 10 words relating to negative affect. The participants is asked to rate how they feel about each word from 1 (very slightly/not at all) to 5 (extremely) with a minimum score of 5 and maximum of 50. A higher score relates to higher negative affect.
Positive Affect Score12, and 24 weeksAs measured by the positive mood scale derived from the Positive and Negative Affect Schedule. This measure consists of 10 words relating to positive affect. The participants is asked to rate how they feel about each word from 1 (very slightly/not at all) to 5 (extremely) with a minimum score of 5 and maximum of 50. A higher score relates to higher positive affect.
Combined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line12, and 24 weeksCombined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, and the Coefficient of the Line for Reaction Time by Length of Sting During Probe Recall. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome
Systolic Blood Pressure12, and 24 weeks.LMM analysis of intervention group x 12 and 24 wk test session. Baseline blood pressure entered as a covariate.

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Placebo
Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen
30
Wild Blueberry Powder - 450mg
Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen
30
Wild Blueberry Powder - 900 mg
Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen
31
Wild Blueberry Extract 100mg
Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen
31
Total122

Baseline characteristics

CharacteristicPlaceboWild Blueberry Powder - 450mgWild Blueberry Powder - 900 mgWild Blueberry Extract 100mgTotal
Age, Continuous70.8 years
STANDARD_DEVIATION 3.07
70.5 years
STANDARD_DEVIATION 2.87
70.3 years
STANDARD_DEVIATION 3.59
70.2 years
STANDARD_DEVIATION 4.3
70.5 years
STANDARD_DEVIATION 3.47
Region of Enrollment
United Kingdom
30 participants30 participants31 participants31 participants122 participants
Sex: Female, Male
Female
16 Participants26 Participants15 Participants18 Participants75 Participants
Sex: Female, Male
Male
14 Participants4 Participants16 Participants13 Participants47 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 300 / 310 / 31
other
Total, other adverse events
1 / 300 / 301 / 312 / 31
serious
Total, serious adverse events
0 / 300 / 300 / 310 / 31

Outcome results

Primary

Combined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.

Combined Z score of proportion of words recalled, proportion of words recognised, and proportion of pictures recognised. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome

Time frame: 12, and 24 weeks

ArmMeasureGroupValue (MEAN)Dispersion
PlaceboCombined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.12 Weeks0.19 z-scoreStandard Error 0.11
PlaceboCombined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.24 Weeks0.31 z-scoreStandard Error 0.09
Wild Blueberry Powder - 450mgCombined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.24 Weeks0.13 z-scoreStandard Error 0.09
Wild Blueberry Powder - 450mgCombined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.12 Weeks0.08 z-scoreStandard Error 0.11
Wild Blueberry Powder - 900 mgCombined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.12 Weeks0.02 z-scoreStandard Error 0.11
Wild Blueberry Powder - 900 mgCombined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.24 Weeks0.33 z-scoreStandard Error 0.08
Wild Blueberry Extract 100mgCombined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.12 Weeks0.28 z-scoreStandard Error 0.11
Wild Blueberry Extract 100mgCombined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.24 Weeks0.2 z-scoreStandard Error 0.09
Primary

Proportion of Words Correctly Recognised.

Participants indicate whether words presented on a monitor are from a list of 15 words previously presented auditorily (via headphones), or if they are novel foils.

Time frame: 12, and 24 weeks

ArmMeasureGroupValue (MEAN)Dispersion
PlaceboProportion of Words Correctly Recognised.12 Weeks0.86 proportion of words correctly recognisedStandard Error 0.02
PlaceboProportion of Words Correctly Recognised.24 Weeks0.90 proportion of words correctly recognisedStandard Error 0.02
Wild Blueberry Powder - 450mgProportion of Words Correctly Recognised.24 Weeks0.88 proportion of words correctly recognisedStandard Error 0.02
Wild Blueberry Powder - 450mgProportion of Words Correctly Recognised.12 Weeks0.85 proportion of words correctly recognisedStandard Error 0.02
Wild Blueberry Powder - 900 mgProportion of Words Correctly Recognised.12 Weeks0.79 proportion of words correctly recognisedStandard Error 0.02
Wild Blueberry Powder - 900 mgProportion of Words Correctly Recognised.24 Weeks0.87 proportion of words correctly recognisedStandard Error 0.02
Wild Blueberry Extract 100mgProportion of Words Correctly Recognised.12 Weeks0.90 proportion of words correctly recognisedStandard Error 0.02
Wild Blueberry Extract 100mgProportion of Words Correctly Recognised.24 Weeks0.88 proportion of words correctly recognisedStandard Error 0.02
Primary

Total Number of Correct Sequences Recalled

Participants view an array of 9 white squares on a monitor which light up red in sequences of between 2 and 9. They are then required to press the correct squares in the sequence they were presented.

Time frame: 12, and 24 weeks

ArmMeasureGroupValue (MEAN)Dispersion
PlaceboTotal Number of Correct Sequences Recalled24 Weeks15.56 Correct number of sequencesStandard Error 0.48
PlaceboTotal Number of Correct Sequences Recalled12 Weeks15.15 Correct number of sequencesStandard Error 0.41
Wild Blueberry Powder - 450mgTotal Number of Correct Sequences Recalled12 Weeks14.27 Correct number of sequencesStandard Error 0.4
Wild Blueberry Powder - 450mgTotal Number of Correct Sequences Recalled24 Weeks16.348 Correct number of sequencesStandard Error 0.47
Wild Blueberry Powder - 900 mgTotal Number of Correct Sequences Recalled12 Weeks15.42 Correct number of sequencesStandard Error 0.39
Wild Blueberry Powder - 900 mgTotal Number of Correct Sequences Recalled24 Weeks15.921 Correct number of sequencesStandard Error 0.46
Wild Blueberry Extract 100mgTotal Number of Correct Sequences Recalled24 Weeks16.302 Correct number of sequencesStandard Error 0.46
Wild Blueberry Extract 100mgTotal Number of Correct Sequences Recalled12 Weeks16.19 Correct number of sequencesStandard Error 0.39
Secondary

Combined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.

Combined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome.

Time frame: 12, and 24 weeks

ArmMeasureGroupValue (MEAN)Dispersion
PlaceboCombined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.12 Weeks0.003 z-scoreStandard Error 0.067
PlaceboCombined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.24 Weeks-0.101 z-scoreStandard Error 0.065
Wild Blueberry Powder - 450mgCombined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.24 Weeks-0.176 z-scoreStandard Error 0.066
Wild Blueberry Powder - 450mgCombined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.12 Weeks0.009 z-scoreStandard Error 0.068
Wild Blueberry Powder - 900 mgCombined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.12 Weeks-0.137 z-scoreStandard Error 0.064
Wild Blueberry Powder - 900 mgCombined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.24 Weeks-0.129 z-scoreStandard Error 0.062
Wild Blueberry Extract 100mgCombined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.12 Weeks-0.037 z-scoreStandard Error 0.067
Wild Blueberry Extract 100mgCombined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.24 Weeks-0.075 z-scoreStandard Error 0.065
Secondary

Combined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line

Combined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, and the Coefficient of the Line for Reaction Time by Length of Sting During Probe Recall. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome

Time frame: 12, and 24 weeks

ArmMeasureGroupValue (MEAN)Dispersion
PlaceboCombined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line12 Weeks0.12 z-scoreStandard Error 0.09
PlaceboCombined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line24 Weeks0.1 z-scoreStandard Error 0.07
Wild Blueberry Powder - 450mgCombined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line24 Weeks-0.01 z-scoreStandard Error 0.07
Wild Blueberry Powder - 450mgCombined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line12 Weeks-0.03 z-scoreStandard Error 0.08
Wild Blueberry Powder - 900 mgCombined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line12 Weeks-0.13 z-scoreStandard Error 0.08
Wild Blueberry Powder - 900 mgCombined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line24 Weeks-0.04 z-scoreStandard Error 0.07
Wild Blueberry Extract 100mgCombined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line12 Weeks0.03 z-scoreStandard Error 0.08
Wild Blueberry Extract 100mgCombined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line24 Weeks0.02 z-scoreStandard Error 0.07
Secondary

Diastolic Blood Pressure

LMM analysis of intervention group x 12 and 24 wk test session. Baseline blood pressure entered as a covariate.

Time frame: 12, and 24 weeks

ArmMeasureGroupValue (MEAN)Dispersion
PlaceboDiastolic Blood Pressure12 Weeks72.70 mmHgStandard Error 1.16
PlaceboDiastolic Blood Pressure24 Weeks71.71 mmHgStandard Error 1.21
Wild Blueberry Powder - 450mgDiastolic Blood Pressure24 Weeks73.54 mmHgStandard Error 1.18
Wild Blueberry Powder - 450mgDiastolic Blood Pressure12 Weeks74.85 mmHgStandard Error 1.13
Wild Blueberry Powder - 900 mgDiastolic Blood Pressure12 Weeks72.30 mmHgStandard Error 1.09
Wild Blueberry Powder - 900 mgDiastolic Blood Pressure24 Weeks71.23 mmHgStandard Error 1.13
Wild Blueberry Extract 100mgDiastolic Blood Pressure12 Weeks72.30 mmHgStandard Error 1.13
Wild Blueberry Extract 100mgDiastolic Blood Pressure24 Weeks71.45 mmHgStandard Error 1.17
p-value: >0.05Linear Mixed Model / Baseline Covariate
Secondary

Heart Rate

LMM analysis of intervention group x 12 and 24 wk test session. Baseline heart rate entered as a covariate.

Time frame: 12, and 24 weeks.

ArmMeasureGroupValue (MEAN)Dispersion
PlaceboHeart Rate24 Weeks68.62 beats/minStandard Error 1.22
PlaceboHeart Rate12 Weeks68.33 beats/minStandard Error 1.02
Wild Blueberry Powder - 450mgHeart Rate24 Weeks67.47 beats/minStandard Error 1.18
Wild Blueberry Powder - 450mgHeart Rate12 Weeks69.16 beats/minStandard Error 0.98
Wild Blueberry Powder - 900 mgHeart Rate24 Weeks67.11 beats/minStandard Error 1.15
Wild Blueberry Powder - 900 mgHeart Rate12 Weeks66.07 beats/minStandard Error 0.95
Wild Blueberry Extract 100mgHeart Rate24 Weeks70.04 beats/minStandard Error 1.19
Wild Blueberry Extract 100mgHeart Rate12 Weeks67.56 beats/minStandard Error 0.99
p-value: >0.05Linear Mixed Model / Baseline Covariate
Secondary

Negative Affect Score

As measured by the negative mood scale derived from the Positive and Negative Affect Schedule. This measure consists of 10 words relating to negative affect. The participants is asked to rate how they feel about each word from 1 (very slightly/not at all) to 5 (extremely) with a minimum score of 5 and maximum of 50. A higher score relates to higher negative affect.

Time frame: 12, and 24 weeks.

ArmMeasureGroupValue (MEAN)Dispersion
PlaceboNegative Affect Score12 Weeks12.04 units on a scaleStandard Error 0.44
PlaceboNegative Affect Score24 Weeks12.17 units on a scaleStandard Error 0.41
Wild Blueberry Powder - 450mgNegative Affect Score24 Weeks12.18 units on a scaleStandard Error 0.4
Wild Blueberry Powder - 450mgNegative Affect Score12 Weeks13.14 units on a scaleStandard Error 0.42
Wild Blueberry Powder - 900 mgNegative Affect Score12 Weeks11.72 units on a scaleStandard Error 0.42
Wild Blueberry Powder - 900 mgNegative Affect Score24 Weeks12.11 units on a scaleStandard Error 0.4
Wild Blueberry Extract 100mgNegative Affect Score12 Weeks11.53 units on a scaleStandard Error 0.44
Wild Blueberry Extract 100mgNegative Affect Score24 Weeks11.57 units on a scaleStandard Error 0.41
p-value: >0.05Linear Mixed Model / Baseline Covariate
Secondary

Positive Affect Score

As measured by the positive mood scale derived from the Positive and Negative Affect Schedule. This measure consists of 10 words relating to positive affect. The participants is asked to rate how they feel about each word from 1 (very slightly/not at all) to 5 (extremely) with a minimum score of 5 and maximum of 50. A higher score relates to higher positive affect.

Time frame: 12, and 24 weeks

ArmMeasureGroupValue (MEAN)Dispersion
PlaceboPositive Affect Score12 Weeks31.29 units on a scaleStandard Error 0.92
PlaceboPositive Affect Score24 Weeks31.06 units on a scaleStandard Error 0.84
Wild Blueberry Powder - 450mgPositive Affect Score24 Weeks31.07 units on a scaleStandard Error 0.82
Wild Blueberry Powder - 450mgPositive Affect Score12 Weeks31.18 units on a scaleStandard Error 0.9
Wild Blueberry Powder - 900 mgPositive Affect Score12 Weeks32.10 units on a scaleStandard Error 0.92
Wild Blueberry Powder - 900 mgPositive Affect Score24 Weeks30.83 units on a scaleStandard Error 0.83
Wild Blueberry Extract 100mgPositive Affect Score12 Weeks31.30 units on a scaleStandard Error 0.92
Wild Blueberry Extract 100mgPositive Affect Score24 Weeks31.96 units on a scaleStandard Error 0.83
p-value: >0.05Linear Mixed Model / Baseline Covariate
Secondary

Systolic Blood Pressure

LMM analysis of intervention group x 12 and 24 wk test session. Baseline blood pressure entered as a covariate.

Time frame: 12, and 24 weeks.

ArmMeasureGroupValue (MEAN)Dispersion
PlaceboSystolic Blood Pressure12 Weeks124.11 mmHgStandard Error 2.09
PlaceboSystolic Blood Pressure24 Weeks119.63 mmHgStandard Error 2.05
Wild Blueberry Powder - 450mgSystolic Blood Pressure24 Weeks122.39 mmHgStandard Error 2.01
Wild Blueberry Powder - 450mgSystolic Blood Pressure12 Weeks124.51 mmHgStandard Error 2.05
Wild Blueberry Powder - 900 mgSystolic Blood Pressure12 Weeks125.16 mmHgStandard Error 2.03
Wild Blueberry Powder - 900 mgSystolic Blood Pressure24 Weeks119.79 mmHgStandard Error 1.99
Wild Blueberry Extract 100mgSystolic Blood Pressure12 Weeks118.62 mmHgStandard Error 2.15
Wild Blueberry Extract 100mgSystolic Blood Pressure24 Weeks114.72 mmHgStandard Error 2.11
p-value: =0.04Linear Mixed Model / Baseline Covariate

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026